Cardiovascular Risk Reduction: What Do Recent Trials With Rosuvastatin Tell Us?

Advances in Therapy - United States
doi 10.1007/s12325-009-0025-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC